Insulin Tolerance Test: Nursing Guide
The insulin tolerance test (ITT) is a high-risk supervised endocrine protocol — not routine venipuncture. IV regular insulin induces controlled hypoglycemia so clinicians can assess growth hormone and cortisol peaks when simpler stimulation tests are unavailable or inconclusive. Nurses provide one-to-one monitoring, verify fasting and medicine holds, confirm rescue supplies before insulin, trend glucose through neuroglycopenic symptoms, and discharge only after capillary glucose exceeds 70 mg/dL (3.9 mmol/L) per protocol.
Contents
Quick Facts
Key Takeaway
ITT validity requires symptomatic hypoglycemia with laboratory glucose below 2.2 mmol/L (<40 mg/dL) — rescue readiness and one-to-one nursing come before any insulin bolus.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Gold-top serum gel (SST) or red-top
Serial timed serum specimens for GH and cortisol — label every draw with exact clock time relative to insulin administration
Serial timed serum draws during supervised ITT (GH and cortisol)
Approximately 1 mL serum per timed draw — follow laboratory minimums
Baseline and serial post-insulin draws per institutional ITT protocol — commonly every 15–30 minutes through hypoglycemic nadir and recovery phase
Eight to ten hours overnight fast required; hold glucocorticoids at least 12 hours when assessing HPA response per Endotext — follow prescriber and unit protocol
Centrifuge and aliquot serum per endocrine laboratory stability policy; transport timed specimens within institutional limits — do not delay labeling of draw times
Supervised test same day; GH and cortisol results commonly 1–3 days
Endocrine specialty laboratory with timed dynamic protocol processing
What is Insulin Tolerance Test?
Insulin Tolerance Test is a supervised dynamic endocrine test in which IV regular insulin induces controlled hypoglycemia to assess pituitary growth hormone secretion and adrenal cortisol (hypothalamic-pituitary-adrenal) response. Endotext describes ITT as a gold-standard provocative test for adult GH deficiency when performed safely with adequate hypoglycemic nadir. Nurses focus on contraindication screening, weight-based insulin dosing, continuous glucose monitoring, rescue treatment readiness, serial specimen timing, and discharge criteria — not independent insulin administration outside the ordered supervised setting.
Overview
Nurses encounter the insulin tolerance test when endocrinology evaluates suspected hypopituitarism, adult growth hormone deficiency, or secondary adrenal insufficiency after fatigue, growth delay patterns, or cortisol axis uncertainty. Endotext notes ITT induces controlled hypoglycemia with IV regular insulin to measure GH and cortisol peaks — a high-risk test requiring epilepsy, coronary artery disease, pregnancy, and advanced age contraindication review before proceeding.
NHS adult ITT protocols require normal ECG and morning cortisol review before testing when institution policy mandates — nurses verify these prerequisites with the endocrine team. One-to-one nursing, IV access, weight-based insulin dosing (0.05–0.1 U/kg if BMI <30; 0.15–0.3 U/kg if BMI ≥30 per Endotext), and immediate access to oral glucose, IV dextrose, glucagon, and hydrocortisone rescue are non-negotiable. Pair interpretation with ACTH and morning cortisol context when Addison disease or hypopituitarism is suspected.
Before any ITT insulin bolus, confirm overnight fast, glucocorticoid hold status when assessing HPA response, weight for dose calculation, contraindication screen (epilepsy, CAD, pregnancy, age >55 per Endotext), ECG and morning cortisol review per NHS protocol when required, and rescue supplies at the bedside. Escalate hypoglycemia symptoms immediately — do not wait for laboratory GH or cortisol results alone.
Controlled Hypoglycemia, Rescue Readiness, and ITT Contraindications
ITT deliberately induces hypoglycemia to stress the GH and HPA axes — it is a high-risk supervised endocrine test, not routine venipuncture. Insulin must not be given until rescue supplies are at the bedside, contraindications are screened, and one-to-one nursing is assigned. Neuroglycopenic symptoms outrank waiting for pending hormone peaks.
- IV insulin given while oral glucose, IV dextrose, glucagon, or hydrocortisone are not immediately available
- Epilepsy, CAD, pregnancy, or age >55 without documented prescriber risk review (Endotext contraindications)
- Active confusion, sweating, or seizure during glucose fall without immediate rescue
- Morning hydrocortisone taken when HPA assessment requires glucocorticoid hold ≥12 hours
Document: weight-based insulin dose, rescue checklist, nadir glucose and symptoms, each timed GH/cortisol draw, rescue treatments, and prescriber notifications.
What ITT Can and Cannot Tell You
This test can help identify:
- Blunted GH peak supporting adult GHD when hypoglycemia is adequate (Endotext peak ≤5 µg/L — institution specific)
- Inadequate cortisol rise suggesting HPA axis insufficiency during valid hypoglycemic stress
- Need for repeat or alternative dynamic testing when nadir hypoglycemia was insufficient
- Immediate safety events requiring rescue and protocol abort documentation
This test cannot:
- Confirm deficiency without symptomatic hypoglycemia and laboratory glucose <2.2 mmol/L (<40 mg/dL)
- Be performed safely in outpatient phlebotomy settings without prescriber-led supervision
- Replace morning cortisol, ACTH, and clinical assessment for Addison disease or pituitary mass
- Validate HPA assessment when glucocorticoids were not held per Endotext guidance
Pre-ITT Safety Verification
Verify
Clarify before insulin when:
- Oral glucose or IV dextrose is not physically at the bedside
- Patient took morning hydrocortisone without documented hold plan
- Overnight fast was broken or weight not obtained for dosing
- Contraindication screen or ECG/morning cortisol review is incomplete per protocol
- One-to-one nursing coverage is not assigned
- Capillary glucose monitoring supplies or IV access is unavailable
- Insulin dose does not match BMI-adjusted Endotext range after prescriber review
Reading ITT GH and Cortisol Peaks With Nadir Validity
Integrate peak GH and cortisol only when hypoglycemia was adequate — symptomatic nadir with laboratory glucose below 2.2 mmol/L. Institution-specific GH cut-offs (Endotext adult peak ≤5 µg/L for GHD) and cortisol thresholds vary by assay. Evaluate outcomes after prescriber review, not from peaks alone after invalid nadir.
| Pattern (general) | May suggest | Nursing focus |
|---|---|---|
| Adequate hypoglycemia + peak GH > institutional cut-off | Adequate GH secretory response | Report peaks; continue hypopituitarism workup per team |
| Adequate hypoglycemia + peak GH ≤5 µg/L (adult Endotext) | Adult GHD pattern | Notify endocrine prescriber; interpret cortisol peak simultaneously |
| Inadequate nadir (<40 mg/dL not achieved) | Invalid ITT for deficiency assessment | Document nadir; communicate invalid test — plan repeat or alternative |
| Blunted cortisol peak with adequate hypoglycemia | HPA insufficiency concern | Urgent prescriber notification; hydrocortisone teaching if confirmed |
ITT Bedside Traps and Rescue Discipline
| Bedside point | Nursing note |
|---|---|
| Rescue not at bedside | NCLEX favorite — never give insulin until oral glucose and IV dextrose are verified present |
| Morning hydrocortisone trap | Patient takes routine steroid before ITT — may invalidate HPA peak unless hold confirmed |
| BMI dosing error | Endotext higher insulin range for BMI ≥30 — under-dosing may prevent valid hypoglycemia |
| Nadir documentation | Symptoms plus lab glucose <40 mg/dL define adequate test — chart both |
| Discharge threshold | Capillary glucose must exceed 70 mg/dL (3.9 mmol/L) before escorted discharge |
| Not venipuncture | ITT belongs in supervised endocrine unit — not outpatient lab walk-in workflow |
ITT in Adult Hypopituitarism Pathways
Diagnostic safety badge: High-risk dynamic test — one-to-one nursing, prescriber attendance, and rescue readiness mandatory before insulin.
Check-before-insulin protocol
- Identity + contraindication screen + fast and weight verification
- ECG and morning cortisol review when NHS protocol requires
- Rescue supply checklist at bedside with one-to-one nurse assigned
- IV access, baseline glucose, timed draw labels prepared
- Prescriber confirms BMI-adjusted insulin dose before bolus
Critical teach-back questions
- “What hypoglycemia symptoms should you tell us about immediately during the test?”
- “Can you confirm when you last ate and whether you took hydrocortisone this morning?”
- “Do you understand you cannot drive until we confirm your blood sugar has recovered?”
Care coordination: endocrine prescriber, endocrine day unit nursing, laboratory timed processing, hydrocortisone replacement education if indicated, and emergency response per institutional protocol.
ITT Quick Clinical Checklist
- Are rescue supplies physically at the bedside before insulin?
- Was overnight fast confirmed and glucocorticoid hold verified when assessing HPA?
- Is BMI-adjusted insulin dose prescriber-approved?
- Was symptomatic nadir <2.2 mmol/L (<40 mg/dL) achieved and documented?
- Is capillary glucose above 70 mg/dL before discharge?
Why Insulin Tolerance Test is Ordered
ITT is reserved for specialist endocrine units when simpler GH or HPA stimulation tests are unavailable, contraindicated, or inconclusive — always with prescriber attendance and documented rescue planning.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Suspected adult growth hormone deficiency | Does GH rise adequately during controlled hypoglycemic stress? | Endotext defines adult GHD when peak GH is ≤5 µg/L during the hypoglycemic phase — thresholds vary by institution and assay; inadequate hypoglycemia invalidates the test. |
| Assessment of HPA axis cortisol reserve | Does cortisol rise appropriately when hypoglycemia stresses the axis? | ITT evaluates cortisol response alongside GH; glucocorticoids must be held ≥12 hours when assessing HPA function per Endotext — document actual medicine use. |
| Hypopituitarism workup when alternative dynamic tests are unsuitable | Do GH and cortisol peaks fit a combined pituitary pattern? | Endocrine teams order ITT in selected adults when glucagon or arginine stimulation is unsuitable; nurses support serial draws and continuous hypoglycemia monitoring with prescriber attendance. |
| Secondary adrenal insufficiency evaluation in supervised settings | Is cortisol secretion inadequate under hypoglycemic stress? | Interpret with morning cortisol, ACTH, and clinical features of hypopituitarism or secondary adrenal insufficiency — ITT is not an outpatient screening test. |
Contraindications and Precautions
ITT is contraindicated or requires specialist deferral when hypoglycemia poses unacceptable risk — nurses halt the protocol and notify prescriber before insulin when any absolute contraindication is present.
- Epilepsy or seizure disorder — hypoglycemia may provoke seizures (Endotext contraindication list).
- Ischemic heart disease or coronary artery disease — hypoglycemic stress may precipitate cardiac events.
- Pregnancy and age >55 years — listed contraindications in Endotext adult ITT guidance; verify institution policy.
- Morning hydrocortisone or other glucocorticoids taken without prescriber-directed hold when assessing HPA response — may falsely normalize cortisol peaks.
- Broken overnight fast or incorrect weight-based insulin dose (BMI-adjusted dosing per Endotext) — risks inadequate or excessive hypoglycemia.
- Rescue glucose, IV dextrose, glucagon, or hydrocortisone not immediately available at bedside — do not administer insulin until rescue readiness is confirmed.
- Neuroglycopenic symptoms (confusion, sweating, altered behavior) with dropping capillary glucose during ITT — initiate rescue per protocol and notify prescriber immediately.
- Seizure, loss of consciousness, hemodynamic instability, or ECG changes during testing — stop ITT and escalate according to facility emergency policy.
- Capillary glucose not recovering above 70 mg/dL (3.9 mmol/L) after rescue treatment — continue monitoring and prescriber notification before discharge.
Patient Preparation
Preparation protects both patient safety and test validity — inadequate hypoglycemia invalidates GH and cortisol peak interpretation.
Pre-test checksReview all glucocorticoids (oral hydrocortisone, prednisone, dexamethasone), anticonvulsants, beta-blockers, and medicines affecting glucose or cortisol. Do not withhold prescribed rescue hydrocortisone for known adrenal insufficiency without explicit prescriber plan — document morning doses taken.
Where the test is performed
This page is a Tests & Diagnostics guide for Insulin Tolerance Test. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Insulin Tolerance Test is a supervised dynamic endocrine test performed in hospital endocrine day units or specialty clinics with one-to-one nursing and prescriber attendance. Nurses focus on fasting and medicine verification, IV access and weight-based insulin dose safety, continuous glucose monitoring, hypoglycemia rescue readiness (oral glucose, IV dextrose, glucagon, and hydrocortisone per protocol), serial timed specimens, and discharge only after glucose recovery — not independent IV insulin bolus administration outside the ordered test setting.
Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation — not equipment operation or departmental imaging protocols.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
ITT results integrate peak GH and cortisol during documented adequate hypoglycemia (symptomatic nadir with laboratory glucose <2.2 mmol/L). Without adequate hypoglycemia, the test is invalid for deficiency assessment — always note nadir glucose, symptoms, and assay-specific thresholds.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Adequate hypoglycemia achieved with GH peak above institutional deficiency cut-off and cortisol rise consistent with protocol — assay and institution specific | GH and cortisol responses appropriate for achieved hypoglycemic stress when protocol integrity confirmed | Communicate peaks and nadir data to endocrine prescriber; continue hypopituitarism workup plan as ordered |
| Borderline / near reference limit | Adequate hypoglycemia with GH or cortisol peak near institutional cut-off | May require repeat ITT or alternative stimulation test — specialist interpretation | Verify nadir documentation; notify endocrine team; avoid definitive deficiency labeling without prescriber review |
| High / above reference interval | GH peak above deficiency threshold during adequate hypoglycemia | Supports adequate GH secretory response during ITT when hypoglycemia was valid — interpret with clinical context | Report peaks to prescriber; correlate with IGF-1, symptoms, and imaging per team plan |
| Low / below reference interval | Peak GH ≤5 µg/L during adequate hypoglycemia (adult Endotext threshold — institution may vary) | May support adult GH deficiency when hypoglycemia was adequate — cortisol peak must be interpreted simultaneously for HPA assessment | Notify endocrine prescriber urgently if cortisol peak also inadequate; plan hydrocortisone replacement teaching if adrenal insufficiency confirmed |
ITT Hypoglycemia and Invalid-Protocol Escalation
Urgent nursing action during ITT centers on hypoglycemia severity and protocol integrity — not isolated pending hormone values. Rescue treatment precedes interpretation when neuroglycopenic symptoms or inadequate nadir invalidates results.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Severe neuroglycopenic hypoglycemia during ITT | Confusion, sweating, seizure, or loss of consciousness with capillary glucose falling during test | Administer rescue per protocol immediately; notify prescriber; stop insulin pathway; monitor until glucose >70 mg/dL (3.9 mmol/L) |
| Inadequate hypoglycemic nadir invalidating ITT | Laboratory glucose ≥2.2 mmol/L (≥40 mg/dL) at nadir or absent neuroglycopenic symptoms when protocol requires adequate hypoglycemia | Notify prescriber that ITT may be invalid for GH/HPA assessment; document nadir and plan repeat or alternative test — do not label deficiency without adequate stress |
| Rescue supplies unavailable or glucocorticoid interference | Insulin prepared while oral glucose not at bedside, or morning hydrocortisone taken without hold when assessing HPA response | Pause insulin administration; notify prescriber; obtain rescue supplies or reschedule when medicine and safety prerequisites are met |
Stop the ITT insulin pathway and escalate according to facility policy when neuroglycopenic symptoms require rescue, when contraindications emerge, when rescue was not ready before testing, or when nadir hypoglycemia was inadequate to interpret GH and cortisol peaks.
Factors Affecting Results
ITT interpretation depends on achieving valid hypoglycemia, accurate timed specimens, and medicine exposures that blunt cortisol or GH responses. Nurses protect validity with fasting verification, glucocorticoid holds, and meticulous nadir documentation.
- Apparent adequate GH peak when hypoglycemia was insufficient — test may falsely reassure
- Cortisol peak preserved because exogenous glucocorticoid was not held ≥12 hours when assessing HPA axis
- Normal GH peak drawn outside hypoglycemic phase due to mistimed serial specimen
- GH deficiency suggested when inadequate hypoglycemia produced subnormal peak — invalid test
- Missed cortisol insufficiency when morning hydrocortisone masked HPA response
- Under-dosed insulin in BMI ≥30 patient when Endotext higher dose range was not used
- Exogenous glucocorticoids and inadequate fasting
- Insufficient insulin dose or obesity without BMI-adjusted dosing
- Mistimed serial draws relative to hypoglycemic nadir
ITT cannot be performed safely with epilepsy, CAD, pregnancy, or age >55 per Endotext contraindications. Without symptomatic hypoglycemia and laboratory glucose <2.2 mmol/L (<40 mg/dL), GH and cortisol peaks cannot confirm or exclude deficiency. Institution-specific GH cut-offs (e.g., adult peak ≤5 µg/L) and cortisol thresholds vary by assay — specialist interpretation is mandatory.
Nursing Responsibilities
Nursing responsibilities center on one-to-one supervision, rescue readiness before insulin, glucose trending, timed specimen coordination, and clear communication when the test is unsafe or invalid.
Before the TestDocumentation
Documentation must prove rescue readiness, adequate or inadequate hypoglycemia, and timed hormone sampling for endocrine interpretation.
“Adult ITT supervised in endocrine day unit; 10-hour fast confirmed; weight 78 kg, BMI 27 — insulin 0.1 U/kg (7.8 units regular IV) per Endotext. Rescue oral glucose, IV dextrose, glucagon, and hydrocortisone verified at bedside before insulin. Nadir capillary glucose 38 mg/dL (2.1 mmol/L) at 09:42 with sweating and confusion; oral glucose and IV dextrose given; prescriber notified. Serial GH/cortisol draws at baseline, +15, +30, +45, +60, +90 minutes labeled. Discharge glucose 92 mg/dL at 11:10 after meal; patient taught late hypoglycemia symptoms.”
- Fasting hours, weight, BMI, and insulin dose calculation with prescriber verification
- Rescue supply checklist completed before insulin administration
- Nadir capillary and laboratory glucose with neuroglycopenic symptoms and time
- Each timed GH/cortisol draw clock time relative to insulin bolus
- Rescue treatments, prescriber notifications, and protocol abort reasons if applicable
- Discharge glucose >70 mg/dL, alertness, and post-test teaching documented
Patient and Family Education
Use plain language about deliberate supervised hypoglycemia, rescue availability, and post-test monitoring — patients must not drive until cleared.
Insulin Tolerance Test NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Insulin Tolerance Test safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Insulin tolerance test (ITT) — IV regular insulin with serial GH and cortisol draws
- Indication: 42-year-old with suspected hypopituitarism; ITT ordered in endocrine day unit
- Timing: Scheduled 08:00 after overnight fast; insulin dose prepared at 08:35
- Related orders: Serial GH and cortisol; baseline ACTH; morning cortisol on chart; ECG reviewed yesterday
- Result: Baseline glucose 92 mg/dL; post-insulin capillary glucose trending down — GH/cortisol peaks pending
- Trend / prior value: Capillary glucose 72 mg/dL → 58 mg/dL → 49 mg/dL over 25 minutes with new sweating and confusion
- Pending tests: Endocrine prescriber in clinic; ITT protocol in progress; discharge criteria not yet met
- Vital signs: HR 96/min, BP 118/72 mmHg, temp 36.7°C, SpO₂ 98% on room air
- Symptoms: New diaphoresis and confusion during glucose fall; previously alert after fast
- Focused assessment: Patient oriented to person only; tremulous; denies chest pain; IV access patent
- Preparation notes: Morning hydrocortisone 10 mg taken at 07:00 — hold status not confirmed with prescriber; oral glucose not stocked at bedside
- Collection events: Insulin 0.1 U/kg administered; +15 and +30 minute draws sent; capillary checks q10 min
- Teaching gaps / safety concerns: Dropping glucose with neuroglycopenic symptoms, rescue glucose not at bedside, morning hydrocortisone taken, ITT contraindication screen not documented on flowsheet
Answer key & rationale
Frequently Asked Questions
FAQ
What does the insulin tolerance test measure?
Endotext describes ITT as a supervised test using IV regular insulin to induce controlled hypoglycemia and assess growth hormone and cortisol (HPA axis) responses — used in selected adult endocrine workups when other stimulation tests are unsuitable.
Who should not undergo an insulin tolerance test?
Endotext lists contraindications including epilepsy, ischemic heart disease, pregnancy, and age over 55 years. Nurses verify institution policy and prescriber clearance before any insulin bolus.
What fasting and medicine preparation is required before ITT?
Patients fast overnight (commonly 8–10 hours). When assessing HPA response, glucocorticoids should be held at least 12 hours per Endotext — only per prescriber instruction. Weight must be obtained for BMI-adjusted insulin dosing.
What insulin dose is used for ITT?
Endotext cites 0.05–0.1 units/kg for BMI below 30 and 0.15–0.3 units/kg for BMI 30 or above. Regular insulin is given IV under prescriber supervision with one-to-one nursing.
When is an ITT considered adequate for interpretation?
Endotext requires symptomatic hypoglycemia with laboratory glucose below 2.2 mmol/L (40 mg/dL). Without adequate hypoglycemia, GH and cortisol peaks cannot reliably assess deficiency.
What GH peak suggests adult growth hormone deficiency on ITT?
Endotext often cites peak GH at or below 5 µg/L during the hypoglycemic phase as supporting adult GHD — thresholds vary by institution and assay. Cortisol peak must be interpreted at the same time.
When can the patient leave after ITT?
Discharge when capillary glucose is above 70 mg/dL (3.9 mmol/L), the patient is alert, and post-test meal and late hypoglycemia teaching are complete per institutional protocol.
References
References
-
Yuen KCJ; et al. Adult Growth Hormone Deficiency. Endotext. MDText.com, Inc.https://www.ncbi.nlm.nih.gov/books/NBK279118/
-
Yuen KCJ; et al. Diagnosis of Growth Hormone Deficiency in Adults. Endotext. MDText.com, Inc.https://www.ncbi.nlm.nih.gov/books/NBK279118/
-
NHS England. Insulin tolerance test — adult endocrine protocol. Specialist endocrine service guidance.https://www.england.nhs.uk/
-
Society for Endocrinology. Dynamic endocrine testing guidance. UK clinical reference.https://www.endocrinology.org/
-
Yuen KCJ; et al. Hypothalamic-Pituitary-Adrenal Axis Testing. Endotext. MDText.com, Inc.https://www.ncbi.nlm.nih.gov/books/NBK279118/
-
National Health Service. Hypopituitarism — diagnosis and monitoring. NHS.uk.https://www.nhs.uk/conditions/hypopituitarism/
-
Melmed S; et al. Williams Textbook of Endocrinology. 15th ed. Elsevier; 2025 — ITT and hypopituitarism (reference text).https://www.ncbi.nlm.nih.gov/books/NBK279118/
-
Burger HG; et al. Insulin tolerance test methodology. Endocrine Society clinical reviews.https://www.endocrine.org/
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Insulin Tolerance Test.
Policies: Medical Review Process · Editorial Policy · Correction Policy